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INTRODUcTION
Several studies have shown that patients with prior transurethral prostate surgery are associated 
with greater perioperative complications, as well as inferior oncological and functional outcomes when 
they undergo robot-assisted radical prostatectomy (RARP). 
Objectives: To the best of our knowledge, there is no study thus far evaluating the association 
between prior transurethral prostate surgery and the above outcomes following Retzius-sparing robot-
-assisted radical prostatectomy (RS-RARP).
MATERIALS AND METHODS
 
A retrospective review of 413 patients who underwent RS-RARP by a single surgeon from No-
vember 2012 to December 2015 was analyzed. There are no certain selection criterions to perform or not 
Retzius-sparing approach. Patients were divided into two groups based on the history of prior transu-
rethral surgery. Patient clinicopathological characteristics, perioperative outcomes as well as short term 
oncological outcome and continence rates up to one year post RS-RARP were compared between the 
two groups.
RESULTS
Seventeen patients (4.1%) underwent prior transurethral prostate surgery. There was no difference 
in the baseline patient clinicopathological characteristics apart from older age in the TURP group. 
Perioperative, and oncological outcomes were comparable between the groups. Continence rates at 
one month, three months, six months and one year post RS- RARP were also similar between the 
two groups.
cONcLUSION
Equivalent perioperative, oncological and functional outcomes were achieved between the two 
groups. RS RARP is a safe and feasible option following previous transurethral prostate surgery.
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B = Bladder 
P = Prostate 
U = Urethra 
BN = Bladder neck 
DF = Denoviller’s fascia 
PF = Pelvic Floor 
NVB = Neurovascular bundle 
DA = detrusor apron
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